Navigating Vaccine Trials for Young Children

This chapter explores the intricate processes of vaccine trials aimed at younger populations, highlighting the concept of immunobridging and the challenges faced by regulators in validating vaccine efficacy. The speakers address the comparatively low risk of severe COVID-19 in young children while discussing parental enthusiasm for vaccination despite current low rates. The chapter also reflects on the broader implications for children's emotional well-being and social development amidst ongoing pandemic precautions.